Asset Management Company β 2015 Investments
3 investments dated 2015 Β· listed companies and verified rows first Β· show all
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Charles Roberts(Director)inGabriel Otte(Director)in
BoardStuart Lawson(Director)
Co-investorsRA CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAverin CapitalBain Capital Life Sciences+8 more
Ooma Direct Routing for Microsoft Teams enables organizations to connect their Teams collaboration platform to the Public Switched Telephone Network for voice calling.
Cloud ComputingConsumerEnterprise SoftwareFuture of WorkSaaSPalo Alto, US
Spencer Jackson(Executive Officer)Eric Stang(Executive Officer, Director)
BoardSean Parker(Director)James Wei(Director)Tim Weingarten(Director)Pete Goettner(Director)
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)
Co-investorsMerck Global Health Innovation FundSamsung VenturesDigiTx Partners LLCExcel Venture ManagementTCP Venture CapitalWindham Capital Partners+1 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.